Calcineurin signaling and PGC-1α expression are suppressed during muscle atrophy due to diabetes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 8, 2010, Pages 960-967

  Roberts Wilson, Tiffany K ^a,b   Reddy, Ramesh N ^a   Bailey, James L ^a   Zheng, Bin ^a   Ordas, Ronald ^a   Gooch, Jennifer L ^a,c   Price, S Russ ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Atrophy; Calcineurin; Diabetes; PGC 1 ; Skeletal muscle; Streptozotocin

Indexed keywords

CALCINEURIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOGENIC FACTOR 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN MCIP1.4; STREPTOZOCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; MYOGENIC FACTOR; PPARGC1A PROTEIN, MOUSE; PPARGC1A PROTEIN, RAT; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; MALE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; MUSCULAR ATROPHY; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; CALCINEURIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOGENIC REGULATORY FACTORS; NFATC TRANSCRIPTION FACTORS; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 77953702287     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.03.019     Document Type: Article

References (49)

1. Sun Z., Liu L., Liu N., Liu Y. Muscular response and adaptation to diabetes mellitus. Front Biosci. 2008, 13:4765-4794.
2. Michael L., Wu Z., Cheatham R., Puigserver P., Adelmant G., Lehman J., Kelly D., Spiegelman B. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. U. S. A. Mar 2001, 98(7):3820-3825.
3. Lin J., Wu H., Tarr P., Zhang C., Wu Z., Boss O., Michael L., Puigserver P., Isotani E., Olson E., Lowell B., Bassel-Duby R., Spiegelman B. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature Aug 2002, 418(6899):797-801.
4. Sacheck J., Hyatt J., Raffaello A., Jagoe R., Roy R., Edgerton V., Lecker S., Goldberg A. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. Jan 2007, 21(1):140-155.
5. Sandri M., Lin J., Handschin C., Yang W., Arany Z., Lecker S., Goldberg A., Spiegelman B. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. U. S. A. Oct 2006, 103(44):16260-16265.
6. Tiao G., Lieberman M., Fischer J.E., Hasselgren P.O. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am. J. Physiol. Mar 1997, 272(3 Pt 2):R849-R856.
7. Mootha V., Lindgren C., Eriksson K., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M., Patterson N., Mesirov J., Golub T., Tamayo P., Spiegelman B., Lander E., Hirschhorn J., Altshuler D., Groop L. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. Jul 2003, 34(3):267-273.
8. Patti M., Butte A., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E., Goldfine A., Mun E., DeFronzo R., Finlayson J., Kahn C., Mandarino L. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. Jul 2003, 100(14):8466-8471.
9. Arany Z. PGC-1 coactivators and skeletal muscle adaptations in health and disease. Curr. Opin. Genet. Dev. Oct 2008, 18(5):426-434.
10. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell Nov 17 1989, 59(4):675-680.
11. Herzig S., Long F., Jhala U., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature Sep 2001, 413(6852):179-183.
12. Chin E., Olson E., Richardson J., Yang Q., Humphries C., Shelton J., Wu H., Zhu W., Bassel-Duby R., Williams R. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. Aug 1998, 12(16):2499-2509.
13. Naya F., Mercer B., Shelton J., Richardson J., Williams R., Olson E. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J. Biol. Chem. Feb 2000, 275(7):4545-4548.
14. Olson E., Williams R. Calcineurin signaling and muscle remodeling. Cell Jun 2000, 101(7):689-692.
15. Savignac M., Gomes B., Gallard A., Narbonnet S., Moreau M., Leclerc C., Paulet P., Mariame B., Druet P., Saoudi A., Fournie G.J., Guery J.C., Pelletier L. Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders. J. Immunol. May 1 2004, 172(9):5206-5212.
16. Sheridan D.C., Carbonneau L., Ahern C.A., Nataraj P., Coronado R. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes. Biophys. J. Dec 2003, 85(6):3739-3757.
17. Bueno O.F., Wilkins B.J., Tymitz K.M., Glascock B.J., Kimball T.F., Lorenz J.N., Molkentin J.D. Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice. Proc. Natl. Acad. Sci. U. S. A. Apr 2 2002, 99(7):4586-4591.
18. Wilkins B., Dai Y., Bueno O., Parsons S., Xu J., Plank D., Jones F., Kimball T., Molkentin J. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. Jan 2004, 94(1):110-118.
19. Zhang B.W., Zimmer G., Chen J., Ladd D., Li E., Alt F.W., Wiederrecht G., Cryan J., O'Neill E.A., Seidman C.E., Abbas A.K., Seidman J.G. T cell responses in calcineurin A alpha-deficient mice. J. Exp. Med. Feb 1 1996, 183(2):413-420.
20. Price S., Bailey J., Wang X., Jurkovitz C., England B., Ding X., Phillips L., Mitch W. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. Oct 1996, 98(8):1703-1708.
21. Waalkes T., Udenfriend S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. Nov 1957, 50(5):733-736.
22. Clark A.S., Mitch W.E. Comparison of protein synthesis and degradation in incubated and perfused muscle. Biochem. J. Jun 15 1983, 212(3):649-653.
23. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. Aug 2001, 2(8):599-609.
24. Zheng Z., Wang Z.M., Delbono O. Insulin-like growth factor-1 increases skeletal muscle dihydropyridine receptor alpha 1S transcriptional activity by acting on the cAMP-response element-binding protein element of the promoter region. J. Biol. Chem. Dec 27 2002, 277(52):50535-50542.
25. Schiaffino S., Serrano A. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol. Sci. Dec 2002, 23(12):569-575.
26. Fenyvesi R., Racz G., Wuytack F., Zador E. The calcineurin activity and MCIP1.4 mRNA levels are increased by innervation in regenerating soleus muscle. Biochem. Biophys. Res. Commun. Jul 23 2004, 320(2):599-605.
27. Yang J., Rothermel B., Vega R., Frey N., McKinsey T., Olson E., Bassel-Duby R., Williams R. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. Dec 2000, 87(12):E61-E68.
28. Olson E.N., Williams R.S. Calcineurin signaling and muscle remodeling. Cell Jun 23 2000, 101(7):689-692.
29. Beals C., Sheridan C., Turck C., Gardner P., Crabtree G. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science Mar 1997, 275(5308):1930-1934.
30. Cross D., Alessi D., Vandenheede J., McDowell H., Hundal H., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. Oct 1994, 303(Pt 1):21-26.
31. Rhodes S., Konieczny S. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. Dec 1989, 3(12B):2050-2061.
32. Black B., Martin J., Olson E. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. Feb 1995, 270(7):2889-2892.
33. Finck B., Kelly D. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. Mar 2006, 116(3):615-622.
34. Lin J., Tarr P., Yang R., Rhee J., Puigserver P., Newgard C., Spiegelman B. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. Aug 2003, 278(33):30843-30848.
35. Rodgers J., Lerin C., Haas W., Gygi S., Spiegelman B., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature Mar 2005, 434(7029):113-118.
36. Uldry M., Yang W., St-Pierre J., Lin J., Seale P., Spiegelman B.M. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab. May 2006, 3(5):333-341.
37. Soyal S., Krempler F., Oberkofler H., Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia Jul 2006, 49(7):1477-1488.
38. Wang X., Hu Z., Hu J., Du J., Mitch W.E. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology Sep 2006, 147(9):4160-4168.
39. Phielix E., Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol. Behav. May 2008, 94(2):252-258.
40. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. Feb 2003, 24(1):78-90.
41. Pietri-Rouxel F., Gentil C., Vassilopoulos S., Baas D., Mouisel E., Ferry A., Vignaud A., Hourde C., Marty I., Schaeffer L., Voit T., Garcia L. DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis. EMBO J. 29 (3) (Feb 2010) 643-654.
42. Bassel-Duby R., Olson E. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 2006, 75:19-37.
43. Schiaffino S., Sandri M., Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) Aug 2007, 22:269-278.
44. Tong J.F., Yan X., Zhu M.J., Du M. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes. J. Cell. Biochem. Oct 1 2009, 108(2):458-468.
45. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell Oct 20 2006, 127(2):397-408.
46. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., Guttridge D.C. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. Aug 2004, 114(3):370-378.
47. Alkner B.A., Tesch P.A. Efficacy of a gravity-independent resistance exercise device as a countermeasure to muscle atrophy during 29-day bed rest. Acta Physiol. Scand. Jul 2004, 181(3):345-357.
48. Fluckey J.D., Dupont-Versteegden E.E., Montague D.C., Knox M., Tesch P., Peterson C.A., Gaddy-Kurten D. A rat resistance exercise regimen attenuates losses of musculoskeletal mass during hindlimb suspension. Acta Physiol. Scand. Dec 2002, 176(4):293-300.
49. Rennie M.J., Wilkes E.A. Maintenance of the musculoskeletal mass by control of protein turnover: the concept of anabolic resistance and its relevance to the transplant recipient. Ann. Transplant. 2005, 10(4):31-34.